Financials
Income statement
| Fiscal date | Mar 2025 | Mar 2024 |
|---|---|---|
| Total reported revenue | 128.3M | 138.5M |
| Cost of revenue | 105.1M | 118.4M |
| Gross profit | 23.2M | 20.1M |
| Operating expense | ||
| Research & development | — | — |
| Selling general and admin | 8.5M | 8.5M |
| Other operating expenses | -1.0M | -1M |
| Operating income | 15.8M | 12.5M |
| Non operating interest income | ||
| Income | 4.5M | 2.3M |
| Expense | 8.9M | 7.4M |
| Other income expense | — | — |
| Pretax income | 8.6M | 7.6M |
| Tax provision | 2.6M | 1.6M |
| Net income | 6.0M | 6.0M |
| Basic EPS | 0.1 | 0.1 |
| Diluted EPS | 0.1 | 0.1 |
| Basic average shares | 50.3M | 50.5M |
| Diluted average shares | 50.3M | 50.5M |
| EBITDA | 18.2M | 15.5M |
| Net income from continuing op. | 6.0M | 6.0M |
| Minority interests | — | — |
| Preferred stock dividends | 0 | 0 |